Lantheus Holdings, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 1956, the company has established itself as a leader in the development and commercialisation of innovative diagnostic and therapeutic products, particularly in the fields of oncology and cardiovascular imaging. Lantheus is renowned for its advanced imaging agents, including the widely used PET imaging agent, which aids in the detection and management of various cancers. The company’s commitment to enhancing patient care through precision medicine has positioned it favourably within the market. With a strong focus on research and development, Lantheus continues to achieve significant milestones, solidifying its reputation as a trusted partner in the healthcare community.
How does Lantheus Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Lantheus Holdings, Inc.'s score of 25 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Lantheus Holdings, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. The company has not disclosed any commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As such, there are no specific figures regarding their Scope 1, 2, or 3 emissions, nor any inherited data from a parent organisation. In the absence of concrete emissions data or reduction commitments, Lantheus Holdings, Inc. appears to be in the early stages of developing a comprehensive climate strategy. The lack of reported emissions and targets highlights a potential area for growth in their sustainability efforts, particularly as the industry increasingly prioritises climate action and transparency.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Lantheus Holdings, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

